Massachusetts-based Neograft raises $11 million in support of its Angioshield polymer sleeve for supporting arterial veins.
Bay State startup Neograft closed an $11 million equity funding round in support of its vascular sleeve technology.
Neograft's Angioshield device "creates a micro-fibrous, polymer sleeve intimately surrounding the outside surface of a harvested vein to mechanically reinforce and protect it from overdilation," according to the company. The technology is not yet approved for clinical use.
Apollo Onyx Delivery Micro Catheter with Detachable Tip Enhances Onyx Liquid Embolic System (LES) Delivery.
FDA regulators give Covidien the stamp of approval for the company's Apollo Onyx delivery micro catheter, the 1st of its kind with a detachable tip.
Medtech giant Covidien (NYSE:COV) this week touted FDA approval for its Apollo Onyx delivery micro catheter, the 1st FDA-approved device of its kind with a detachable tip.
Kansas bioscience incubator Novita spins out Flow Forward with vascular access devices for hemodialysis patients.
Early state vascular devices maker Flow Forward emerged from the nest, so to speak, spinning out of the Novita life sciences incubator in Olathe, Kansas.
Founded in 2011, Flow Forward is taking with it the AFE System, a device intended to help more patients undergo hemodialysis via an arteriovenous fistula (AVF), the gold standard in vascular access sites.
Reverse Medical wins FDA approval to launch U.S. clinical trials of its Barrel vascular reconstruction device for use in treating aneurysms.
California-based Reverse Medical landed key FDA approval to launch U.S. clinical trials of its Barrel vascular reconstruction device for treatment of intracranial bifurcation aneurysms.
The company plans to finalize its trial structure "very soon" and begin enrolling patients within the next few months, president & CEO Jeffrey Valko said in prepared remarks.
Analogic says it won 510(k) clearance from the FDA for its Sonic Window, a handheld ultrasound device for visualizing the vasculature for peripheral IV access.
Analogic (NSDQ:ALOG) said it won 510(k) clearance from the FDA for its handheld Sonic Window ultrasound device, designed to help caregivers view the vasculature to guide peripheral IV placement.
Bi02 Medical, which makes the Angel vena cava filter catheter, reports a nearly $6 million equity round.
Bi02 Medical, maker of the Angel vena cava filter catheter, said it raised nearly $5.9 million in a hoped-for $7.5 million equity offering.
The funding round for the San Antonio, Texas-based medical device company involved 10 unnamed investors, according to a regulatory filing.